Pharmaceutical Management Agency

Request for Proposals - Supply of rituximab, infliximab and tocilizumab

Pharmac invites proposals for the supply of rituximab, infliximab and tocilizumab in New Zealand.

This request for proposals (RFP) letter incorporates the following schedules:
· Schedule 1 specifies the pharmaceuticals for which Pharmac is requesting proposals and sets out the background to the RFP and the types of proposals sought;
· Schedule 2 describes the process that Pharmac expects to follow in relation to the RFP;
· Schedule 3 sets out information about the estimated size of the current subsidised market and estimated forecasted market for the pharmaceuticals;
· Attachment 1 is the form in which you can provide non-price information;
· Attachment 2 is the form in which you can provide price information;
· Attachment 3 contains Pharmac’s standard terms and conditions for supply of pharmaceuticals;
· Attachment 4 contains the standard Principal Supply Status terms; and.
· Attachment 5 is the New Zealand Government Supplier Code of Conduct.

If you wish to submit a proposal, you must submit it to Pharmac via the Government Electronic Tenders Service (GETS) no later than 12:00 p.m. (New Zealand time) on 2 September 2026.

If you have any enquiries about this RFP you should submit them via GETS prior to 12:00 p.m. (New Zealand time) on 19 August 2026. Responses to all enquires will be published on GETS. If you do need to get in touch via email, please contact procurement@pharmac.govt.nz

We will also be holding an online supplier briefing at 1:00 p.m. (New Zealand time) on Tuesday 4 August. If you are interested in attending this, please register your interest by emailing procurement@pharmac.govt.nz

We look forward to receiving your proposal.